STOCK TITAN

Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Penumbra (NYSE: PEN) has scheduled its first quarter 2025 earnings release and conference call for April 23, 2025. The company will release its Q1 2025 financial results after market close, followed by a conference call at 4:30 PM Eastern Time.

Investors and interested parties can access the conference call by dialing (888) 596-4144 with conference ID 6572573, or via webcast through the 'Events and Presentations' section on Penumbra's website. The webcast recording will remain available for a minimum of two weeks after the call.

Penumbra (NYSE: PEN) ha programmato il rilascio dei risultati finanziari del primo trimestre 2025 e la relativa conferenza telefonica per il 23 aprile 2025. L'azienda pubblicherà i risultati finanziari del Q1 2025 dopo la chiusura del mercato, seguiti da una conferenza telefonica alle 16:30 ora orientale.

Gli investitori e le parti interessate possono accedere alla conferenza telefonica componendo il numero (888) 596-4144 con l'ID conferenza 6572573, oppure tramite webcast nella sezione 'Eventi e Presentazioni' del sito web di Penumbra. La registrazione del webcast rimarrà disponibile per un minimo di due settimane dopo la chiamata.

Penumbra (NYSE: PEN) ha programado la publicación de sus resultados financieros del primer trimestre de 2025 y la conferencia telefónica correspondiente para el 23 de abril de 2025. La compañía dará a conocer sus resultados financieros del Q1 2025 después del cierre del mercado, seguido de una conferencia telefónica a las 4:30 PM, hora del Este.

Los inversores y partes interesadas pueden acceder a la conferencia telefónica marcando el (888) 596-4144 con el ID de conferencia 6572573, o a través de un webcast en la sección 'Eventos y Presentaciones' del sitio web de Penumbra. La grabación del webcast estará disponible por un mínimo de dos semanas después de la llamada.

페넘브라 (NYSE: PEN)는 2025년 1분기 실적 발표 및 컨퍼런스 콜을 2025년 4월 23일로 예정했습니다. 회사는 시장 마감 후 2025년 1분기 재무 결과를 발표하고, 동부 표준시 기준 오후 4시 30분에 컨퍼런스 콜을 진행합니다.

투자자 및 관심 있는 분들은 (888) 596-4144로 전화하여 회의 ID 6572573을 입력하거나 페넘브라 웹사이트의 '이벤트 및 발표' 섹션을 통해 웹캐스트에 접속할 수 있습니다. 웹캐스트 녹음은 통화 후 최소 2주 동안 이용 가능합니다.

Penumbra (NYSE: PEN) a programmé la publication de ses résultats financiers du premier trimestre 2025 et la conférence téléphonique qui l'accompagne pour le 23 avril 2025. L'entreprise publiera ses résultats financiers du T1 2025 après la fermeture du marché, suivis d'une conférence téléphonique à 16h30, heure de l'Est.

Les investisseurs et les parties intéressées peuvent accéder à la conférence téléphonique en composant le (888) 596-4144 avec l'ID de conférence 6572573, ou via un webinaire dans la section 'Événements et Présentations' du site web de Penumbra. L'enregistrement du webinaire sera disponible pendant au moins deux semaines après l'appel.

Penumbra (NYSE: PEN) hat die Veröffentlichung der Ergebnisse des ersten Quartals 2025 und die dazugehörige Telefonkonferenz für den 23. April 2025 angesetzt. Das Unternehmen wird seine finanziellen Ergebnisse für das Q1 2025 nach Börsenschluss bekannt geben, gefolgt von einer Telefonkonferenz um 16:30 Uhr Eastern Time.

Investoren und interessierte Parteien können an der Telefonkonferenz teilnehmen, indem sie (888) 596-4144 mit der Konferenz-ID 6572573 wählen oder über das Webcast in der Rubrik 'Veranstaltungen und Präsentationen' auf der Website von Penumbra. Die Aufzeichnung des Webcasts bleibt mindestens zwei Wochen nach dem Anruf verfügbar.

Positive
  • None.
Negative
  • None.

ALAMEDA, Calif., April 3, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2025 after market close on Wednesday, April 23, 2025 at 4:30 PM Eastern Time. A press release with first quarter 2025 financial results will be issued after market close that day.

Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 6572573), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.

About Penumbra
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.

Investor Relations
Penumbra, Inc.
investors@penumbrainc.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-schedules-first-quarter-2025-earnings-release-and-conference-call-for-april-23-2025-302415998.html

SOURCE Penumbra, Inc.

FAQ

When will Penumbra (PEN) release its Q1 2025 earnings?

Penumbra will release its Q1 2025 earnings after market close on Wednesday, April 23, 2025.

How can investors join Penumbra's Q1 2025 earnings call?

Investors can join by dialing (888) 596-4144 (ID: 6572573) or accessing the webcast through Penumbra's website.

What time is Penumbra's Q1 2025 earnings conference call?

The earnings conference call is scheduled for 4:30 PM Eastern Time on April 23, 2025.

How long will Penumbra's Q1 2025 earnings webcast be available?

The webcast will be available for at least two weeks following the earnings call on Penumbra's website.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Stock Data

10.50B
36.94M
3.93%
92.35%
3.52%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA